Medical informatics - Linking diseases, drugs, and adverse reactions
•Als PPT, PDF herunterladen•
0 gefällt mir•293 views
Medical informatics - Linking diseases, drugs, and adverse reactions
Empfohlen
Empfohlen
Weitere ähnliche Inhalte
Was ist angesagt?
Was ist angesagt? (13)
Andere mochten auch
Andere mochten auch (13)
Ähnlich wie Medical informatics - Linking diseases, drugs, and adverse reactions
Ähnlich wie Medical informatics - Linking diseases, drugs, and adverse reactions (20)
Mehr von Lars Juhl Jensen
Mehr von Lars Juhl Jensen (20)
Kürzlich hochgeladen
Kürzlich hochgeladen (20)
Medical informatics - Linking diseases, drugs, and adverse reactions
- 1. Medical informatics Linking diseases, drugs, and adverse reactions Lars Juhl Jensen
- 3. Jensen et al., Nature Reviews Genetics, 2012
- 9. opt-out
- 10. opt-in
- 11. registry data
- 14. CPR number
- 15. Jensen et al., Nature Reviews Genetics, 2012
- 17. 14 years
- 22. ICD-10
- 23. Jensen et al., Nature Reviews Genetics, 2012
- 24. not research
- 25. reimbursement
- 27. comorbidity
- 29. Jensen et al., Nature Reviews Genetics, 2012
- 31. “known knowns”
- 32. gender
- 33. age
- 34. type of hospital encounter
- 35. Jensen et al., Nature Communications, 2014
- 36. “known unknowns”
- 37. smoking
- 38. diet
- 40. reporting biases
- 41. matched controls
- 42. proxy diagnoses
- 45. Jensen et al., Nature Communications, 2014
- 47. Jensen et al., Nature Communications, 2014
- 48. key diagnoses
- 49. Jensen et al., Nature Communications, 2014
- 51. clinical text
- 54. free text
- 55. Danish
- 57. busy doctors
- 58. abbreviations
- 59. misspellings
- 60. a lot of it
- 61. computer
- 62. as smart as a dog
- 63. teach it specific tricks
- 68. diseases
- 69. drugs
- 71. synonyms
- 75. expansion rules
- 77. Clozapine
- 79. “black list”
- 82. clinical trials
- 85. underreporting
- 86. text/data mining
- 87. medication
- 88. Jensen et al., Nature Reviews Genetics, 2012
- 89. adverse events
- 92. Eriksson et al., Drug Safety, 2014 Drug introduction Drug discontinuationAdverse event Adverse eventNegative modifier Indication Pre-existing condition Adverse drug reaction Possible adverse drug reaction ADR of additional drug
- 93. Eriksson et al., Drug Safety, 2014 Drug introduction Drug discontinuationAdverse eventIdentification start Adverse eventNegative modifier Indication Pre-existing condition Adverse drug reaction Possible adverse drug reaction ADR of additional drug
- 94. Eriksson et al., Drug Safety, 2014 Drug introduction Drug discontinuation Adverse eventNegative modifier Indication Pre-existing condition Adverse drug reaction Possible adverse drug reaction Adverse event ADR of additional drug Identification start
- 95. Eriksson et al., Drug Safety, 2014 Drug introduction Drug discontinuation Adverse eventNegative modifier Indication Pre-existing condition Adverse drug reaction Possible adverse drug reaction Adverse event ADR of additional drug Identification start
- 98. Eriksson et al., Drug Safety, 2014
- 100. Drug substance ADE p-value Chlordiazepoxide Nystagmus 4.0e-8 Simvastatin Personality changes 8.4e-8 Dipyridamole Visual impairment 4.4e-4 Citalopram Psychosis 8.8e-4 Bendroflumethiazi de Apoplexy 8.5e-3 Eriksson et al., Drug Safety, 2014
- 101. Acknowledgments Disease trajectories Anders Bøck Jensen Tudor Oprea Pope Moseley Søren Brunak Adverse drug reactions Robert Eriksson Thomas Werge Søren Brunak EHR text mining Peter Bjødstrup Jensen Robert Eriksson Henriette Schmock Francisco S. Roque Anders Juul Marlene Dalgaard Massimo Andreatta Sune Frankild Eva Roitmann Thomas Hansen Karen Søeby Søren Bredkjær Thomas Werge Søren Brunak